Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | USLM | CRH |
|---|---|---|
| Price | $110.78 | $82.65 |
| Change today | ▼ 0.21% | ▲ 0.87% |
| Market cap | $3.18B | $54.99B |
| Return, 3 months | +11.0% | -21.9% |
| Return, year to date | -7.3% | -33.0% |
| Return, 1 year | -12.5% | -29.0% |
| P/E (TTM) | 23.7 | 14.6 |
| P/B | 4.6 | 2.3 |
| P/E percentile vs own 5y | 59th | 35th |
| Dividend yield | 0.22% | 1.84% |
| Revenue growth (YoY, latest qtr) | – | +5.6% |
| Net profit growth (YoY) | – | +13.4% |
| Gross margin | – | 36.2% |
| Operating margin | – | 14.1% |
| Net margin | – | 9.9% |
| Return on equity | – | 16.4% |
| Analyst target vs. price | – | +62.9% |
| Analyst buy share | – | 100% |
| RSI (14) | 42 | 34 |
| 30-day volatility | 23.4% | 25.2% |
| Max drawdown, 1 year | -30.1% | -37.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
